Sirupio vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,429,062 | 1,638,399 | 1,451,715 | 1,851,661 | 2,796,216 | 2,205,653 | 2,132,980 | 2,003,587 |
| Profit before tax | 24,315 | 40,274 | -204,722 | -170,637 | -22,575 | 448,580 | 146,031 | 125,097 |
| Net profit | - | - | - | - | -23,169 | 427,386 | 130,430 | 105,043 |
| Equity | -19,501 | 17,081 | -188,257 | -359,439 | -382,608 | 44,778 | 175,198 | 200,241 |
| Liabilities | - | - | - | - | 1,439,329 | 770,998 | 380,425 | 296,081 |
| Non-current assets | 94,290 | 652,551 | 1,068,625 | 1,075,204 | 602,908 | 425,657 | 241,350 | 112,047 |
| Current assets | 365,735 | 411,921 | 515,518 | 678,779 | 453,813 | 390,119 | 314,273 | 384,275 |
| Total assets | 460,025 | 1,064,472 | 1,584,143 | 1,753,983 | 1,056,721 | 815,776 | 555,623 | 496,322 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 239,086 | 233,206 | 188,157 |
| Social insurance contributions | - | - | - | - | - | 87,119 | 80,442 | 76,929 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +131.4% | +14.6% | -11.4% | +27.5% | +51.0% | -21.1% | -3.3% | -6.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | -2.2% | 52.4% | 23.5% | 21.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | 954.5% | 74.4% | 52.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | -0.8% | 19.4% | 6.1% | 5.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.7% | 2.5% | -14.1% | -9.2% | -0.8% | 20.3% | 6.8% | 6.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | 17.2 | 2.2 | 1.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 51,344 | 60,681 | 52,314 | 72,378 | 118,150 | 129,744 | 124,858 | 134,318 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Sirupio vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-05-02 | 2023-05-14 | 0.41 |
| 2023-04-27 | 2023-04-28 | 0.41 |
| 2023-04-25 | 2023-04-25 | 0.41 |
| 2023-03-16 | 2023-03-19 | 271.74 |
| 2022-01-28 | 2022-02-13 | 0.03 |
| 2021-10-18 | 2021-10-19 | 22.30 |
Sirupio vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-30 | 2026-08-13 | 0.32 |
| 2026-05-15 | 2026-05-18 | 5265.71 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Sirupio vaistine, UAB (code 147764059) is a Private Limited Liability Company engaged in retail sale of pharmaceutical products. In 2025, the company generated EUR 2.00M in revenue, down 6.1% year on year and 9.2% compared with 2023. Net profit was EUR 105.0K, with a profit margin of 5.2%, continuing the downward trend from EUR 427.4K in 2023 and EUR 130.4K in 2024. Even so, the company remained profitable across the full period. The balance sheet also contracted: total assets declined to EUR 496.3K from EUR 815.8K in 2023, while equity increased to EUR 200.2K and liabilities fell to EUR 296.1K. The equity ratio was 40.3% and debt-to-equity stood at 1.48. Return on equity reached 52.5% and return on assets 21.2%, supported by asset turnover of 4.04x. Revenue per employee was EUR 143.1K and profit per employee EUR 7.5K.